Skip to main content
Premium Trial:

Request an Annual Quote

PTC Therapeutics Takes $35M Series E

NEW YORK, Jan. 7 (GenomeWeb News) -- PTC Therapeutics of South Plainfield, NJ, announced today the closing of a $35 million Series E round of funding led by CSFB Private Equity and HBM Bioventures.

 

Additional investors included Bay City Capital, Delphi Ventures, Hansa Special Opportunities Fund Ltd., HealthCap, Novartis BioVentures, Novo A/S, POSCO BioVentures and Vulcan Capital.

 

The six-year-old company, which focuses on RNA biology, particularly gene-expression modulation by small molecules, has raised $91 million in venture capital funding. 

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.